References |
Top |
REF 1 |
miR-146a-mediated suppression of the inflammatory response in human adipocytes. Sci Rep. 2016 Dec 6;6:38339.
|
REF 2 |
Toll-like 4 receptor /NFB inflammatory/miR-146a pathway contributes to the ART-correlated preterm birth outcome. Oncotarget. 2016 Nov 8;7(45):72475-72485.
|
REF 3 |
Up-regulated microRNA-146a negatively modulate Helicobacter pylori-induced inflammatory response in human gastric epithelial cells. Microbes Infect. 2010 Oct;12(11):854-63.
|
REF 4 |
microRNA-146a inhibits G protein-coupled receptor-mediated activation of NF-B by targeting CARD10 and COPS8 in gastric cancer. Mol Cancer. 2012 Sep 20;11:71.
|
REF 5 |
MicroRNA mediation of endothelial inflammatory response to smooth muscle cells and its inhibition by atheroprotective shear stress. Circ Res. 2015 Mar 27;116(7):1157-69.
|
REF 6 |
Histone deacetylase inhibitors increase microRNA-146a expression and enhance negative regulation of interleukin-1 signaling in osteoarthritis fibroblast-like synoviocytes. Osteoarthritis Cartilage. 2013 Dec;21(12):1987-96.
|
REF 7 |
miR-146a regulates mechanotransduction and pressure-induced inflammation in small airway epithelium. FASEB J. 2012 Aug;26(8):3351-64.
|
REF 8 |
NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A. 2006 Aug 15;103(33):12481-6.
|
REF 9 |
Downregulation of microRNA 46a inhibits ovarian granulosa cell apoptosis by simultaneously targeting interleukin receptorssociated kinase and tumor necrosis factor receptorssociated factor 6. Mol Med Rep. 2015 Oct;12(4):5155-62.
|
REF 10 |
MicroRNA-146 inhibits pro-inflammatory cytokine secretion through IL-1 receptor-associated kinase 1 in human gingival fibroblasts. J Inflamm (Lond). 2013 May 16;10(1):20.
|
REF 11 |
Clinical significance of miR-146a in gastric cancer cases. Clin Cancer Res. 2011 Jul 1;17(13):4277-84.
|
REF 12 |
Nuclear factor-{kappa}B contributes to anaplastic thyroid carcinomas through up-regulation of miR-146a. J Clin Endocrinol Metab. 2010 Mar;95(3):1421-30.
|
REF 13 |
Presenilin 2 influences miR146 level and activity in microglia. J Neurochem. 2013 Dec;127(5):592-9.
|
REF 14 |
miR-146a suppresses cellular immune response during Japanese encephalitis virus JaOArS982 strain infection in human microglial cells. J Neuroinflammation. 2015 Feb 18;12:30.
|
REF 15 |
miR-146a-5p Antagonized AGEs- and P.g-LPS-Induced ABCA1 and ABCG1 Dysregulation in Macrophages via IRAK-1 Downregulation. Inflammation. 2015 Oct;38(5):1761-8.
|
REF 16 |
Dysregulation of miRNA146a versus IRAK1 induces IL-17 persistence in the psoriatic skin lesions. Immunol Lett. 2012 Dec 17;148(2):151-62.
|
REF 17 |
Mechanistic role of microRNA-146a in endotoxin-induced differential cross-regulation of TLR signaling. J Immunol. 2011 Feb 1;186(3):1723-34.
|
REF 18 |
Formation of GW/P bodies as marker for microRNA-mediated regulation of innate immune signaling in THP-1 cells. Immunol Cell Biol. 2010 Feb;88(2):205-12.
|
REF 19 |
miR-146a induces differentiation of periodontal ligament cells. J Dent Res. 2010 Mar;89(3):252-7.
|
REF 20 |
Expression of microRNA-146 suppresses NF-kappaB activity with reduction of metastatic potential in breast cancer cells. Oncogene. 2008 Sep 18;27(42):5643-7.
|
REF 21 |
IRAK1, a Target of miR-146b, Reduces Cell Aggressiveness of Human Papillary Thyroid Carcinoma. J Clin Endocrinol Metab. 2016 Nov;101(11):4357-4366.
|
REF 22 |
HCV-induced miR-21 contributes to evasion of host immune system by targeting MyD88 and IRAK1. PLoS Pathog. 2013;9(4):e1003248.
|
REF 23 |
The BDNF Val66Met variant affects gene expression through miR-146b. Neurobiol Dis. 2015 May;77:228-37.
|